Skip to main content
UNH
NYSE Finance

UnitedHealth Q2 earnings surge 61% on lower medical costs, but membership declines

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Financial
Sentiment info
Positive
Importance info
9
Price
$408.7
Mkt Cap
$371.195B
52W Low
$244.37
52W High
$461.62
52W Position info
67% above low
Off High info
11% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

UNH sits 67% above its 52-week low of $244.37.

Summary

UnitedHealth's Q2 2026 earnings jumped 61% to $6.04 per share as medical costs fell sharply, but membership dropped by 1.6 million people amid pricing actions and Medicaid redeterminations.


Key Events · Earnings and Guidance · UNH

  • Q2 EPS Soars 61%

    Diluted EPS of $6.04 vs $3.74 a year ago, driven by a 2.7 percentage point improvement in the medical care ratio to 86.7%.

  • Medical Costs Drop Sharply

    Medical costs fell $3.2 billion to $75.4 billion, reflecting favorable prior-period reserve development of $1.25 billion and lower utilization.

  • Membership Declines by 1.6 Million

    UnitedHealthcare served 1.6 million fewer people, with declines in Medicare Advantage (785,000), Medicaid (710,000), and commercial risk (785,000).

  • Operating Cash Flow Hits $20 Billion

    Cash from operations for the first half of 2026 reached $20.0 billion, up from $12.6 billion a year ago, boosted by higher earnings and working capital.


Analysis · UNH · Finance

A sharp drop in the medical care ratio to 86.7% from 89.4% powered UnitedHealth Group to a massive Q2 beat, with diluted EPS of $6.04—up 61% from $3.74 a year ago. The improvement reflected favorable prior-period reserve development and disciplined cost management, even as the company shed 1.6 million members across Medicare Advantage, commercial risk, and Medicaid. Operating cash flow reached $20 billion for the half, and a $1.5 billion acquisition was completed. However, the IRS is challenging transfer pricing for 2017–2020, and membership losses signal ongoing pressure from Medicare funding cuts and state Medicaid rate disputes.

At the time of this filing, UNH was trading at $408.70 on NYSE in the Finance sector, with a market capitalization of approximately $371.2B. The 52-week trading range was $244.37 to $461.62. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

UNH - Latest Insights

UNH
Jul 29, 2026, 6:50 AM EDT
Source: Benzinga
Importance Score:
8
Price at Filing: $426.42
Real-time Price: $408.31 info
Change: -$18.11 (-4%) info
Market Cap: $371.195B info
UNH
Jul 17, 2026, 3:14 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $426.77
Real-time Price: $408.31 info
Change: -$18.46 (-4%) info
Market Cap: $371.195B info
UNH
Jul 16, 2026, 6:00 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $447.99
Real-time Price: $408.31 info
Change: -$39.68 (-9%) info
Market Cap: $371.195B info
UNH
Jul 16, 2026, 5:55 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $417.00
Real-time Price: $408.31 info
Change: -$8.69 (-2%) info
Market Cap: $371.195B info
UNH
Jun 18, 2026, 3:13 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $399.90
Real-time Price: $408.31 info
Change: +$8.41 (+2%) info
Market Cap: $371.195B info